Related Experiment Video
Updated: Jun 22, 2025
10:34
Probing RNA Structure with Dimethyl Sulfate Mutational Profiling with Sequencing In Vitro and in Cells
Published on: December 9, 2022
4.1K
Advances in structural-guided modifications of siRNA
Qiang Li1, Mingxin Dong2, Pu Chen3
1Department of Medicinal Chemistry, School of Pharmacy, Qingdao University, Qingdao 266021, China; Research and Development Department, NanoPeptide (Qingdao) Biotechnology Ltd., Qingdao, China.
Bioorganic & Medicinal Chemistry
|July 2, 2024
Summary
Chemically modified small interfering RNA (siRNA) drugs are advancing RNA interference (RNAi) therapeutics. These modifications enhance drug stability, specificity, and efficacy, paving the way for new treatments.
Area of Science:
- Biochemistry
- Molecular Biology
- Pharmacology
Background:
- The US Food and Drug Administration (FDA) has approved six small interfering RNA (siRNA) drugs, highlighting the therapeutic potential of RNA interference (RNAi).
- Successful siRNA therapeutics rely on chemical modifications and effective delivery systems.
- Chemical modifications to siRNA can improve resistance to degradation, enhance stability and specificity, and prolong drug efficacy.
Purpose of the Study:
- To analyze the correlation between chemical modifications and structure-guided siRNA design.
- To review essential strategies for optimizing siRNA therapeutics.
Main Methods:
- Comprehensive analysis of existing literature on siRNA chemical modifications.
- Examination of structure-activity relationships in siRNA drug design.
- Review of strategies for enhancing siRNA stability, delivery, and targeting.
Main Results:
- Specific chemical modifications, including 2'-modifications, 2',4'-dual modifications, non-canonical sugar modifications, and phosphonate mimics, are critical for siRNA activity.
- Strategies for enhancing overhang stability, RISC loading, strand selection, and reducing off-target effects are essential for effective siRNA therapeutics.
- Targeted delivery approaches are a key area for future development.
Conclusions:
- Chemical modifications are fundamental to the efficacy and stability of siRNA therapeutics.
- Optimizing siRNA design through structure-guided modifications and strategic delivery is crucial for advancing RNAi-based treatments.
- Further research into targeted delivery will expand the potential of siRNA drugs.
Related Concept Videos
02:30siRNA - Small Interfering RNAs
16.7K
Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
16.7K
01:23RNA Interference
26.0K
RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
26.0K
02:30Small interfering RNAs (siRNA)
3.5K
3.5K
02:15Experimental RNAi
6.1K
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
6.1K
02:23RNA Editing
9.0K
RNA editing is a post-transcriptional modification where a precursor mRNA (pre-mRNA) nucleotide sequence is changed by base insertion, deletion, or modification. The extent of RNA editing varies from a few hundred bases, in mitochondrial DNA of trypanosomes, to a just single base, in nuclear genes of mammals. Even a single base change in the pre-mRNA can convert a codon for one amino acid into the codon for another amino acid or a stop codon. This type of re-coding can significantly affect the...
9.0K